Attached files

file filename
10-Q - FORM 10-Q - BIOCLINICA INCw79467e10vq.htm
EX-10.1 - EX-10.1 - BIOCLINICA INCw79467exv10w1.htm
EX-31.1 - EX-31.1 - BIOCLINICA INCw79467exv31w1.htm
EX-32.1 - EX-32.1 - BIOCLINICA INCw79467exv32w1.htm
EX-31.2 - EX-31.2 - BIOCLINICA INCw79467exv31w2.htm
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     In connection with the Quarterly Report on Form 10-Q of BioClinica, Inc. (the “Company”) for the quarter ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Ted I. Kaminer, Executive Vice President of Finance and Administration and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of BioClinica, Inc.
         
     
Dated: August 10, 2010  /s/ Ted I. Kaminer*    
  Ted I. Kaminer, Executive Vice President of Finance and   
  Administration and Chief Financial Officer
(Principal Financial and Accounting Officer) 
 
 
 
*   A signed original of this written statement required by Section 906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or its staff upon request.